Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Pan HX, Qiu LX, Liang Q, Chen Z, Zhang ML, Liu S, Zhong GH, Zhu KX, Liao MJ, Hu JL, Li JX, Xu JB, Fan Y, Huang Y, Su YY, Huang SJ, Wang W, Han JL, Jia JZ, Zhu H, Cheng T, Ye XZ, Li CG, Wu T, Zhu FC, Zhang J, Xia NS.
Pan HX, et al. Among authors: zhang ml.
Lancet Infect Dis. 2024 Apr 10:S1473-3099(24)00159-2. doi: 10.1016/S1473-3099(24)00159-2. Online ahead of print.
Lancet Infect Dis. 2024.
PMID: 38614117